BETAMETHASONE VALERATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Betamethasone Valerate, and what generic alternatives are available?
Betamethasone Valerate is a drug marketed by Novast Labs, Padagis Israel, Taro, Xiromed, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Anima, Teva Pharms, and Actavis Mid Atlantic. and is included in nineteen NDAs.
The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betamethasone Valerate
A generic version of BETAMETHASONE VALERATE was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETAMETHASONE VALERATE?
- What are the global sales for BETAMETHASONE VALERATE?
- What is Average Wholesale Price for BETAMETHASONE VALERATE?
Summary for BETAMETHASONE VALERATE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 19 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Clinical Trials: | 18 |
Patent Applications: | 5,014 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BETAMETHASONE VALERATE |
What excipients (inactive ingredients) are in BETAMETHASONE VALERATE? | BETAMETHASONE VALERATE excipients list |
DailyMed Link: | BETAMETHASONE VALERATE at DailyMed |
![BETAMETHASONE VALERATE drug patent expirations Drug patent expirations by year for BETAMETHASONE VALERATE](/p/graph/s/t/BETAMETHASONE_VALERATE-patent-expirations.png)
![Drug Prices for BETAMETHASONE VALERATE](/p/graph/drug-price/BETAMETHASONE+VALERATE.png)
Recent Clinical Trials for BETAMETHASONE VALERATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 1 |
Queen Mary Hospital, Hong Kong | Phase 3 |
Assiut University | Phase 4 |
Pharmacology for BETAMETHASONE VALERATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for BETAMETHASONE VALERATE
Anatomical Therapeutic Chemical (ATC) Classes for BETAMETHASONE VALERATE
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LUXIQ | Foam | betamethasone valerate | 0.12% | 020934 | 1 | 2007-08-10 |
US Patents and Regulatory Information for BETAMETHASONE VALERATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | BETAMETHASONE VALERATE | betamethasone valerate | AEROSOL, FOAM;TOPICAL | 207144-001 | May 24, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmaderm | BETAMETHASONE VALERATE | betamethasone valerate | OINTMENT;TOPICAL | 018864-001 | Aug 31, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmaderm | BETAMETHASONE VALERATE | betamethasone valerate | CREAM;TOPICAL | 018860-002 | Aug 31, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |